Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DS Stage I Multiple Myeloma”

299 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 299 results

Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Large-scale testing (Phase 3)Study completedNCT00049673
What this trial is testing

Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
NCIC Clinical Trials Group 332
Testing effectiveness (Phase 2)Ended earlyNCT00635024
What this trial is testing

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 1
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Early research (Phase 1)Study completedNCT00258245
What this trial is testing

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 5
Large-scale testing (Phase 3)Study completedNCT00017602
What this trial is testing

Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Genta Incorporated
Testing effectiveness (Phase 2)Study completedNCT00514137
What this trial is testing

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
National Cancer Institute (NCI) 13
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)WithdrawnNCT00112879
What this trial is testing

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma+1 more
The Cleveland Clinic
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Not applicableStudy completedNCT01653106
What this trial is testing

Randomized Trial of Cryotherapy Duration Prior to High Dose Melphalan in Myeloma Patients

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Ohio State University Comprehensive Cancer Center 148
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Early research (Phase 1)Ended earlyNCT00469820
What this trial is testing

Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)Study completedNCT00002787
What this trial is testing

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 22
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Testing effectiveness (Phase 2)Study completedNCT00003954
What this trial is testing

Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT01706666
What this trial is testing

Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
Mayo Clinic 3
Load More Results